Sell Alerts: Novo Nordisk (NVO) and Dr. Pepper Snapple Group (DPS)
NVO was recommended in Dick Davis Investment Digest issue 672 dated June 2, 2010,
around $76.
DPS was recommended in issue 667, dated March 17, 2010, around $36.
As I’ve said before, an investor’s best defense is a strong offense. So this month I am recommending you find a good time to sell the following stocks: Dr. Pepper Snapple Group (DPS) [and] Novo Nordisk (NVO). [Both have] been holds for us for the past few months. Because they all pay a decent dividend, I wanted to wait a little longer to see if earnings season would help increase buying pressure.
However, I now want us to sell before their earnings announcements. None of these stocks is expected to outperform the industry average in terms of earnings growth. This does not live up to our high standards here at Blue Chip Growth, and we have plenty of better opportunities to focus on this month, so now is a good time to take profits.
The good news is that all of these stocks are in the green this year, and my long-time readers will be locking in healthy profits on these sales. We will be recording triple-digit returns on NVO (104.6%) [and] double-digit profits on DPS (38.2%). ...
After selling these positions, I recommend that you review your portfolio and equally weight your positions, rebalancing where necessary. As always, you can put that money back to work in this month’s new buys, as well our Top 5 stocks for August.
Louis Navellier, Blue Chip Growth, www.bluechipgrowth.com, 800-718-8289, August 2013